Retest previous resistance then leg up past yesterday highTesting yesterdays open area. Bid supporting price now support and legged up to test yesterday's high and continue to new highsLongby brentp33Updated 0
MRNA short-term Vaccine playToday it seems like moderna breakout from bull flag, but a relatively mediocre volume and slight rejection of the higher price does not indicates much of an impulsive upward due to vaccine-hysteria. Enter the trade? Maybe I would only consider a short-term play, but without insider information on vaccine progress/news boost, I advise you to be cautious. PS: Please post your views on the long-term fundamental potentials of this company in the comment section, Feel free to leave a thumbs up or down This is not investing advice, please seek professionals, personal ideas worth sharingLongby jerryz73001Updated 0
MRNA seeing greenReady to pop? Briefly broke through resistance and tomorrow maybe the day. I think the Regeneron / Trump news has kept this stock from jumping, but check out the interview with Moncef Slaoui "Trump's Vaccine Czar says the first vaccine should be submitted for emergency authorization around Thanksgiving". The interview suggests that these vaccines will be RNA vaccines, otherwise MRNA and BNTX/PFE approvals. Moncef was on the board at MRNA before he began work for the Administration's Operation Warp Speed. Longby DaBears11
MRNA Bullish weekMRNA is again entering in the trend line, I think the price will continue to go up in the next couple of days. WDYT?Longby maupr92667
Buy Zone and Target for Moderna $MRNAMy buy zone and target for MRNA (Not financial advice)Longby IrregularUntenablePassport334
MRNA: You Would Not Want Better Than ThatFalling Wedge TP1 = 71.72 expected increase 5.59% TP2 = 73.85 expected increase 8.88% TP3 = 76.70 expected increase 12.88% TP4 = 81.18 expected increase 19.33% Please don't forget to FOLLOW, LIKE, and COMMENT... If you like my analysis:) Thank you and Good Luck!Longby KlejdiCuniUpdated 121220
My two cents on my most profitable traded stock this year, MRNAI have traded MRNA more than any other stock. Even if you lack the experience and know-how of trading, following some basics trends will give you a high winning percentage with this stock. 1) Finding the premarket high and shorting the stock close to that gives you about an 85% chance of a 50cent-$1 move before market opens. 2) A lot of the news on this stock is old and reused. Today for example there is news that seniors exhibit very few health issues with the stock. This is old news. 3) With every single run up including the first major one close to $100 a few months back, MRNA has flushed 100% of the time with no ability to maintain the premarket levels. Short02:51by cazmuh1
I had a lame effort a liitle while ago but the media is bad Media is scattered and the good news run ups have been bad. Still the tech is great and will see what happensLongby jays22b2
Live Intraday Trading - Trading a BULL FLAG formation in ModernaA very nice formation in Moderna , at the same time it get's help from market to go higher . What else do you want to make money in the stock market .Long06:26by Sturdy_Intraday_Trading2
MRNA bullish signal. SL close below pink zone. TP in green zoneMRNA bullish signal. SL close below pink zone. TP in green zoneLongby Therealbouga0
MRNA HOLD BULLISHI am not swinging this one, even though it is tempting. I recently sold NVAX at 15% profit, and due to strong correlation with MRNA I was considering selling my MRNA as well, in which case I would have made 14% right now. However, I decided to hold because of 2 reasons : 1) AstraZeneca just took a major hit (if you don't know about it, catch up on the news). This takes out a bit of competition and investor fund distribution might come this way 2) MRNA shows a strong uptrend with good momentum, and that is mainly why I will HOLD it for longer term. Hit like if you found this helpful and interesting. Thanks, Eby BlockTechEvUpdated 9912
MRNA - THE CEO THAT SOLD - SHARE YOUR FEEDBACKPLEASE READ THE ENTIRE POST, IT MIGHT JUST SAVE YOU A SOUR INVESTMENT I have been following MRNA for about a month now, and something interesting has happened that not many people know about. On 4 September, news came out that the CMO, the President AND the CEO have sold large if not all of their holdings.* Now the company says that this is no reason to panic. (sounds like what we were told about corona in December...) On the trading platform I use, I have also gotten a notification about insiders selling. This is a built in strategy used along with others to determine the market consensus of the stock (buy, strong buy, hold etc) We can all probably agree that when head management sell most of their holdings, and not 1 person but 3 senior members, it is generally not a good sign. Now here is where I'd like your feedback - The large selling off their stocks hasn't been reflecting in the market. In fact, MRNA has been on one long bull run with minor short term bearish chart patterns. Why would it be that the sell off doesn't reflect in the market? I personally sold my stock immediately after I saw a report on this from Gurufinder, later confirmed by more mainstream news and other platforms. My opinion is that The company has to portray that they believe their stocks are going all the way up which in this case, selling off massive holdings at the peak tells me that they are taking their profit. Compare this to PFE (Pfizer), whos director INCREASED his holdings. Now that speaks of confidence in the company, right? * INFO FROM MY TRADING PLATFORM CEO, SOLD $1,293,810, DATE 18.09.20 PRESIDENT, SOLD $1,228,468, DATE 15.09.20 CMO, SOLD $1,255,321, DATE 15.09.20 Please share your constructive and respectful feedback, and thank you ! Hit like if you found this interesting, Evby BlockTechEv7710
MRNA: Timeline of Clinical Trials; Operation Warp SpeedThis is a timeline of funding related to the US Government's Operation Warp Speed. MRNA and NVAX are the two stocks that have reacted strongly (in both directions) to any kind of COVID news. You can see that towards the end of phase 1 trials, they disclosed grade 3 adverse reactions to the vaccine which led to a -50% drop in the stock. Longby ZombieStarUpdated 3